CH674935A5 - - Google Patents

Download PDF

Info

Publication number
CH674935A5
CH674935A5 CH2389/87A CH238987A CH674935A5 CH 674935 A5 CH674935 A5 CH 674935A5 CH 2389/87 A CH2389/87 A CH 2389/87A CH 238987 A CH238987 A CH 238987A CH 674935 A5 CH674935 A5 CH 674935A5
Authority
CH
Switzerland
Prior art keywords
calcium
pharmaceutical composition
composition according
organic
powder
Prior art date
Application number
CH2389/87A
Other languages
English (en)
French (fr)
Inventor
Jean-Marc Gailly
Daniel Gomez
Martine Burguiere
Andre Gens
Jean Remy
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH674935A5 publication Critical patent/CH674935A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH2389/87A 1986-07-01 1987-06-26 CH674935A5 (US07579456-20090825-P00002.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609515A FR2600893B1 (fr) 1986-07-01 1986-07-01 Nouvelles compositions pharmaceutiques a base de sels de calcium

Publications (1)

Publication Number Publication Date
CH674935A5 true CH674935A5 (US07579456-20090825-P00002.png) 1990-08-15

Family

ID=9336917

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2389/87A CH674935A5 (US07579456-20090825-P00002.png) 1986-07-01 1987-06-26

Country Status (31)

Country Link
US (1) US4867977A (US07579456-20090825-P00002.png)
JP (1) JPS6322522A (US07579456-20090825-P00002.png)
KR (1) KR950014449B1 (US07579456-20090825-P00002.png)
AT (1) AT392588B (US07579456-20090825-P00002.png)
AU (1) AU597992B2 (US07579456-20090825-P00002.png)
BE (1) BE1007686A4 (US07579456-20090825-P00002.png)
CA (1) CA1305057C (US07579456-20090825-P00002.png)
CH (1) CH674935A5 (US07579456-20090825-P00002.png)
CY (1) CY1684A (US07579456-20090825-P00002.png)
DE (1) DE3720510C2 (US07579456-20090825-P00002.png)
DK (1) DK173508B1 (US07579456-20090825-P00002.png)
ES (1) ES2006192A6 (US07579456-20090825-P00002.png)
FI (1) FI89329C (US07579456-20090825-P00002.png)
FR (1) FR2600893B1 (US07579456-20090825-P00002.png)
GB (1) GB2192131B (US07579456-20090825-P00002.png)
GR (1) GR871015B (US07579456-20090825-P00002.png)
HK (1) HK80393A (US07579456-20090825-P00002.png)
HU (1) HU199283B (US07579456-20090825-P00002.png)
IE (1) IE60430B1 (US07579456-20090825-P00002.png)
IL (1) IL83032A (US07579456-20090825-P00002.png)
IT (1) IT1216829B (US07579456-20090825-P00002.png)
LU (1) LU86932A1 (US07579456-20090825-P00002.png)
MY (1) MY101750A (US07579456-20090825-P00002.png)
NL (1) NL194749C (US07579456-20090825-P00002.png)
NO (1) NO175041B (US07579456-20090825-P00002.png)
NZ (1) NZ220898A (US07579456-20090825-P00002.png)
PH (1) PH25430A (US07579456-20090825-P00002.png)
PT (1) PT85212B (US07579456-20090825-P00002.png)
SE (1) SE502567C2 (US07579456-20090825-P00002.png)
SG (1) SG123192G (US07579456-20090825-P00002.png)
ZA (1) ZA874769B (US07579456-20090825-P00002.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621486A5 (US07579456-20090825-P00002.png) * 1977-01-27 1981-02-13 Fischer Artur
JP2665764B2 (ja) * 1988-04-20 1997-10-22 日水製薬株式会社 カルシウム水溶液剤
EP0346866A3 (en) * 1988-06-16 1990-07-11 Biochemie Gesellschaft M.B.H. Composition for the prophylaxis of osteoporosis
WO1993012672A1 (en) * 1991-12-26 1993-07-08 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
ATE198122T1 (de) * 1992-10-21 2001-01-15 Procter & Gamble Konzentrierte, bioverfügbare kalziumquelle
JP3199743B2 (ja) * 1992-10-21 2001-08-20 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウムを補給した貯蔵安定な飲料用濃縮プレミックス及びシロップ
WO1994008471A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
US5942255A (en) * 1996-07-15 1999-08-24 The University Of Memphis Methods of enhancing lean tissue mass and bone mineral content and compositions therefor
US6235322B1 (en) * 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
BRPI0215795B1 (pt) * 2002-06-27 2018-07-17 Torres Buendia Manuel processo de fabricação de gliconolactato de cálcio
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
US20040258818A1 (en) * 2003-06-20 2004-12-23 Kraft Foods Holdings, Inc. Reduced acidic flavor in acidified starch products
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090298946A1 (en) * 2008-06-02 2009-12-03 Cleavelin Cody R Local Anesthetic Deactivation
WO2019126262A1 (en) * 2017-12-20 2019-06-27 Dsm Ip Assets B.V. Materials and methods for dietary calcium supplementation of animals
AU2020400638A1 (en) * 2019-12-12 2022-06-23 Alberta Veterinary Laboratories Ltd. Choline bolus compositions for ruminants
CN113749205B (zh) * 2021-09-09 2024-08-06 山东凯翔生物科技股份有限公司 一种葡萄糖酸钙-葡萄糖酸复合粉的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1526981A (en) * 1923-02-02 1925-02-17 Upjohn Co Effervescent alkali compound and process of manufacturing and preparing the same
US1616587A (en) * 1926-08-25 1927-02-08 Upjohn Co Method of manufacturing effervescent alkali compounds
US1765867A (en) * 1928-12-15 1930-06-24 Henry G Granger Method for making candy
US2603569A (en) * 1950-01-23 1952-07-15 Joseph G Alther Effervescent drink concentrate
US2639238A (en) * 1952-07-02 1953-05-19 Joseph G Alther Effervescent drink concentrate
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3061445A (en) * 1959-04-30 1962-10-30 Abbott Lab Effervescent sweetening tablet
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
US3241977A (en) * 1962-01-02 1966-03-22 Gen Foods Corp Effervescent beverage powders
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
US3489572A (en) * 1966-04-04 1970-01-13 Benjamin Eisenstadt Sweetening composition
AU2332470A (en) * 1969-12-15 1972-06-15 Sandoz Patents Limited Improvements in or relating to organic compounds
US3939289A (en) * 1973-04-02 1976-02-17 General Foods Corporation Dry carbonation source for a beverage concentrate and method of preparing the same
US3965273A (en) * 1973-04-02 1976-06-22 General Foods Corporation Dry carbonation source and method for preparing the same, and dry carbonated beverage concentrate
US4237147A (en) * 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4009292A (en) * 1975-02-26 1977-02-22 General Foods Corporation Effervescent dipeptide sweetener tablets
US4206244A (en) * 1978-02-06 1980-06-03 Persian Delight, Inc. Dry mix for preparing a carbonated yogurt
JPS5585385A (en) * 1978-12-22 1980-06-27 Mitsuma Miyoshi Powdered food and drink
JPS57122925A (en) * 1981-01-26 1982-07-31 Ajinomoto Co Inc Tablet composition
US4551342A (en) * 1983-02-01 1985-11-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
JPS59166057A (ja) * 1983-03-14 1984-09-19 Ajinomoto Co Inc ジペプチド甘味料含有発泡錠剤の製造法
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4760138A (en) * 1984-12-13 1988-07-26 Nestec S. A. Carbonating agents and their preparation
JPS62501843A (ja) * 1985-02-19 1987-07-23 ボ−ド・オブ・リ−ジェンツ・ザ・ユニバ−シティ−・オブ・テキサス・システム 食事のカルシウム補足によるオステオポロ−シス抑制
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby

Also Published As

Publication number Publication date
AT392588B (de) 1991-04-25
FI872871A (fi) 1988-01-02
KR880001295A (ko) 1988-04-22
IL83032A (en) 1991-05-12
PT85212A (en) 1987-07-01
NL194749B (nl) 2002-10-01
CY1684A (en) 1993-10-10
FI89329B (fi) 1993-06-15
ZA874769B (en) 1989-02-22
AU7491387A (en) 1988-01-07
ATA164187A (de) 1990-10-15
HU199283B (en) 1990-02-28
DE3720510A1 (de) 1988-01-07
IL83032A0 (en) 1987-12-20
AU597992B2 (en) 1990-06-14
NZ220898A (en) 1991-04-26
GB8715216D0 (en) 1987-08-05
GB2192131B (en) 1990-04-04
BE1007686A4 (fr) 1995-10-03
DK333487A (da) 1988-01-02
MY101750A (en) 1992-01-17
CA1305057C (en) 1992-07-14
IT8748100A0 (it) 1987-06-25
SG123192G (en) 1993-02-19
DK333487D0 (da) 1987-06-29
NL8701440A (nl) 1988-02-01
NO872712L (no) 1988-01-04
IE60430B1 (en) 1994-07-13
NL194749C (nl) 2003-02-04
FI872871A0 (fi) 1987-06-29
KR950014449B1 (ko) 1995-11-28
HUT49481A (en) 1989-10-30
IT1216829B (it) 1990-03-14
FR2600893B1 (fr) 1990-01-12
SE8702712D0 (sv) 1987-06-30
PH25430A (en) 1991-07-01
NO872712D0 (no) 1987-06-29
US4867977A (en) 1989-09-19
NO175041C (US07579456-20090825-P00002.png) 1994-08-24
HK80393A (en) 1993-08-13
IE871730L (en) 1988-01-01
SE502567C2 (sv) 1995-11-13
DE3720510C2 (de) 2002-12-19
NO175041B (no) 1994-05-16
FR2600893A1 (fr) 1988-01-08
PT85212B (pt) 1990-03-30
ES2006192A6 (es) 1989-04-16
FI89329C (fi) 1993-09-27
JPS6322522A (ja) 1988-01-30
GB2192131A (en) 1988-01-06
DK173508B1 (da) 2001-01-15
SE8702712L (sv) 1988-01-02
GR871015B (en) 1987-11-02
LU86932A1 (fr) 1988-01-20

Similar Documents

Publication Publication Date Title
BE1007686A4 (fr) Nouvelles compositions pharmaceutiques a base de sels de calcium.
US5869119A (en) Method of reducing distress in mammals due to ingestion of acidic foods and beverages
FR2948029A1 (fr) Ameliorations de compositions et relatives a des compositions de nettoyage du colon
EP0233853A1 (fr) Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation
RU2262336C2 (ru) Быстрорастворимые гранулы и способ их получения
WO1996029993A1 (fr) Forme d'administration solide a usage oral
EP0242244B1 (fr) Composition pharmaceutique consistant en une suspension de carbonate de calcium
FR2601249A1 (fr) Nouvelles compositions pharmaceutiques a base de sels de calcium.
IL44774A (en) Pharmaceutical composition containing acetyl salicyclic acid
FR2913338A1 (fr) Composition de rehydratation.
EP0806949B1 (fr) Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
FR3114943A1 (fr) Formulation pulvérulente pour la préparation d’ une boisson gazéifiée
CA2909750C (fr) Composition pharmaceutique, dietetique ou alimentaire liquide ou semi-liquide depourvue d'amertume contenant un sel d'arginine
US4515805A (en) Soluble sodium cromoglycate compositions
FR2987559A1 (fr) Nouvelles compositions pharmaceutiques a base d'un sel ferreux et leurs utilisations en therapeutique infantile
BE1019425A5 (fr) Ameliorations de compositions et relatives a des compositions de nettoyage du colon.
FR2684848A1 (fr) Utilisation du glucomannane pour la preparation d'une gelee orale a effet de satiete et gelee orale comprenant du glucomannane a effet de satiete ainsi obtenue.
GB2086227A (en) Sodium cromoglycate reconstitutable powders
FR2715564A1 (fr) Composition pharmaceutique contenant de la N-acétyl-cystéine.
BE544584A (US07579456-20090825-P00002.png)
MXPA98000655A (en) Food neutralization aci

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased